Robert B. Flint

1.0k total citations
63 papers, 585 citations indexed

About

Robert B. Flint is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Robert B. Flint has authored 63 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pediatrics, Perinatology and Child Health, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Robert B. Flint's work include Pharmaceutical studies and practices (17 papers), Neonatal Respiratory Health Research (13 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Robert B. Flint is often cited by papers focused on Pharmaceutical studies and practices (17 papers), Neonatal Respiratory Health Research (13 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Robert B. Flint collaborates with scholars based in Netherlands, Belgium and France. Robert B. Flint's co-authors include Sinno H. P. Simons, Karel Allegaert, Birgit C. P. Koch, Catherijne A. J. Knibbe, Irwin Reiss, Swantje Völler, Dick Tibboel, Paola Mian, Peter Andriessen and Bart C.H. van der Nagel and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and International Journal of Environmental Research and Public Health.

In The Last Decade

Robert B. Flint

60 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Flint Netherlands 14 214 136 104 89 72 63 585
Tamorah Lewis United States 13 291 1.4× 151 1.1× 27 0.3× 89 1.0× 49 0.7× 45 516
David J. Gagnon United States 16 97 0.5× 64 0.5× 173 1.7× 107 1.2× 125 1.7× 51 842
E Autret France 17 284 1.3× 176 1.3× 142 1.4× 201 2.3× 56 0.8× 87 908
Donald B. Wiest United States 16 160 0.7× 161 1.2× 54 0.5× 69 0.8× 87 1.2× 30 617
Aida Kulo Bosnia and Herzegovina 14 268 1.3× 60 0.4× 144 1.4× 67 0.8× 63 0.9× 55 596
C. Andrew Robinson United States 17 57 0.3× 66 0.5× 108 1.0× 155 1.7× 76 1.1× 43 840
Jocelyn M. Hicks United States 17 130 0.6× 110 0.8× 40 0.4× 69 0.8× 59 0.8× 31 757
Tessa Ververs Netherlands 16 209 1.0× 112 0.8× 141 1.4× 87 1.0× 15 0.2× 33 798
Pyry A. J. Välitalo Netherlands 18 355 1.7× 53 0.4× 243 2.3× 90 1.0× 176 2.4× 33 860
Dominique Vodovar France 15 47 0.2× 86 0.6× 104 1.0× 208 2.3× 34 0.5× 73 791

Countries citing papers authored by Robert B. Flint

Since Specialization
Citations

This map shows the geographic impact of Robert B. Flint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Flint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Flint more than expected).

Fields of papers citing papers by Robert B. Flint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Flint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Flint. The network helps show where Robert B. Flint may publish in the future.

Co-authorship network of co-authors of Robert B. Flint

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Flint. A scholar is included among the top collaborators of Robert B. Flint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Flint. Robert B. Flint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flint, Robert B., et al.. (2025). Prediction of Vancomycin Area Under the Curve With Trough Concentrations Only: Performance Evaluation of Pediatric Population Pharmacokinetic Models. The Journal of Infectious Diseases. 231(5). e882–e890. 1 indexed citations
2.
Beynum, Ingrid M. van, et al.. (2025). The maternal exposure of digoxin and flecainide in relation to the safety and effectiveness in the treatment of non-hydropic fetal tachycardia. Heart Rhythm. 22(11). 3020–3027. 1 indexed citations
3.
Ramlakhan, Karishma P., Jolien W. Roos‐Hesselink, Jaimi Greenslade, et al.. (2024). Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 410. 132234–132234. 4 indexed citations
4.
5.
Keij, Fleur M., Gerdien A. Tramper‐Stranders, René F. Kornelisse, et al.. (2024). A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta‐Lactamase Inhibition. Clinical Pharmacology & Therapeutics. 117(1). 193–202. 2 indexed citations
6.
Cornette, Jérôme, et al.. (2023). Maternal, fetal, neonatal and breastmilk flecainide concentration during maternal therapy and lactation: a case report. International Breastfeeding Journal. 18(1). 21–21. 1 indexed citations
7.
Smit, Cornelis, Samira Samiee‐Zafarghandy, Sinno H. P. Simons, et al.. (2022). Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?. Neonatology. 120(1). 81–89. 4 indexed citations
8.
9.
Peeters, Laura, et al.. (2021). An Accidental Repetitive 10-Fold Overdose of Sildenafil in a Young Infant with Pulmonary Hypertension. Neonatology. 118(3). 354–358. 1 indexed citations
10.
Völler, Swantje, Christian F. Poets, Catherijne A. J. Knibbe, et al.. (2021). The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age. Neonatology. 118(1). 106–113. 13 indexed citations
11.
Abdulla, Alan, Robert B. Flint, Karel Allegaert, et al.. (2021). Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review. Frontiers in Pediatrics. 9. 624639–624639. 37 indexed citations
12.
Flint, Robert B., Justin Skowno, Paul Davies, et al.. (2020). Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists. European Journal of Clinical Pharmacology. 77(4). 625–635. 20 indexed citations
13.
Helder, Onno K., Joost van Rosmalen, Martine De Vos, et al.. (2020). Effect of the use of an antiseptic barrier cap on the rates of central line–associated bloodstream infections in neonatal and pediatric intensive care. American Journal of Infection Control. 48(10). 1171–1178. 10 indexed citations
14.
Flint, Robert B., Sinno H. P. Simons, Peter Andriessen, et al.. (2020). The bioavailability and maturing clearance of doxapram in preterm infants. Pediatric Research. 89(5). 1268–1277. 8 indexed citations
15.
Flint, Robert B., Swantje Völler, Irwin Reiss, et al.. (2020). Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus. British Journal of Clinical Pharmacology. 86(10). 2028–2039. 15 indexed citations
16.
Flint, Robert B., Soma Bahmany, Bart C.H. van der Nagel, & Birgit C. P. Koch. (2018). Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto‐doxapram in plasma using liquid chromatography–tandem mass spectrometry. Biomedical Chromatography. 32(10). e4290–e4290. 10 indexed citations
17.
Flint, Robert B., Rob ter Heine, Edwin Spaans, et al.. (2018). Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns. European Journal of Clinical Pharmacology. 74(12). 1585–1591. 12 indexed citations
18.
Flint, Robert B., Peter Andriessen, Luc J. I. Zimmermann, et al.. (2018). Large differences in neonatal drug use between NICUs are common practice: time for consensus?. British Journal of Clinical Pharmacology. 84(6). 1313–1323. 25 indexed citations
19.
Flint, Robert B., et al.. (2017). Pharmacokinetics of S‐ketamine during prolonged sedation at the pediatric intensive care unit. Pediatric Anesthesia. 27(11). 1098–1107. 13 indexed citations
20.
Flint, Robert B., Daniëlla Roofthooft, Anne van Rongen, et al.. (2017). Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants. Pediatric Research. 82(4). 678–684. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamorah Lewis Breakdown of academic impact, for papers by David J. Gagnon Breakdown of academic impact, for papers by E Autret Breakdown of academic impact, for papers by Donald B. Wiest Breakdown of academic impact, for papers by Aida Kulo Breakdown of academic impact, for papers by C. Andrew Robinson Breakdown of academic impact, for papers by Jocelyn M. Hicks Breakdown of academic impact, for papers by Tessa Ververs Breakdown of academic impact, for papers by Pyry A. J. Välitalo Breakdown of academic impact, for papers by Dominique Vodovar
Rankless by CCL
2026